These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28781011)

  • 1. Pre-operative proteinuria in left ventricular assist devices and clinical outcome.
    Muslem R; Caliskan K; Akin S; Sharma K; Gilotra NA; Brugts JJ; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Manintveld OC; Russell SD
    J Heart Lung Transplant; 2018 Jan; 37(1):124-130. PubMed ID: 28781011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Topkara VK; Coromilas EJ; Garan AR; Li RC; Castagna F; Jennings DL; Yuzefpolskaya M; Takeda K; Takayama H; Sladen RN; Mancini DM; Naka Y; Radhakrishnan J; Colombo PC
    Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27932533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices.
    Parikh U; Lamba H; Ajmal M; Vincent J; Walther C; Shafii A; Nair A; Civitello A; Liao K; Chatterjee S
    J Artif Organs; 2021 Jun; 24(2):207-216. PubMed ID: 33598826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.
    Asleh R; Schettle S; Briasoulis A; Killian JM; Stulak JM; Pereira NL; Kushwaha SS; Maltais S; Dunlay SM
    Mayo Clin Proc; 2019 Jun; 94(6):1003-1014. PubMed ID: 31171114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury and 1-year mortality after left ventricular assist device implantation.
    Muslem R; Caliskan K; Akin S; Sharma K; Gilotra NA; Constantinescu AA; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Russell SD; Manintveld OC
    J Heart Lung Transplant; 2018 Jan; 37(1):116-123. PubMed ID: 29174532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support.
    Kurihara C; Kawabori M; Sugiura T; Critsinelis AC; Wang S; Cohn WE; Civitello AB; Frazier OH; Morgan JA
    Artif Organs; 2018 Jun; 42(6):589-596. PubMed ID: 29473181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.
    Pasrija C; Tran D; George P; Sorensen E; Kaczorowski DJ; Ton VK; Kon ZN;
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1307-1319.e2. PubMed ID: 31128896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation.
    Muslem R; Caliskan K; Akin S; Yasar YE; Sharma K; Gilotra NA; Kardys I; Houston B; Whitman G; Tedford RJ; Hesselink DA; Bogers AJJC; Manintveld OC; Russell SD
    Am J Cardiol; 2017 Dec; 120(12):2221-2225. PubMed ID: 29037445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.